How to decrease the cost of pacemaker infection treatment by adopting seemingly costly innovation? A budget impact analysis of a leadless pacemaker implantation

Single-chamber leadless pacemaker Aveir VR implantation: Pioneer experience in Poland. Insights and preliminary report from a multicenter national registry

“…The limitation of the present study is its design: relatively small and rather "typical" group of patients treated and peri-procedural device performance studied. The safety and effectiveness of the new leadless pacemaker, costeffectiveness [11] and applications in rare, challenging clinical cases [12] warrant further observations.…”

Nearly half a century of cardiac pacing evolution: A patient’s journey through epicardial, transvenous, and leadless pacemakers

“…This type of stimulation features a reduced risk of cardiovascular implantable electronic device-related infection and allows safe and feasible implantation procedure at the time of or within a short period after TLE which may support patients' lifespan, especially in pacemaker dependency. This case highlights the patient's extensive journey through various modes of cardiac stimulation, mirroring the evolution of pacemaker technology and may be an option of a cost-effective approach for patients with high risk of cardiovascular implantable electronic device-related infection [5].…”

Infections of cardiac implantable electronic devices: Epidemiology, mechanisms, and preventive measures

“…High costs and lack of reimbursement are among the factors limiting their use in clinical practice. However, when considering total costs for the management of patients with recurrent CIED infections, leadless pacemaker implantation seems to be financially justified, at least in some healthcare systems [62].…”